NCT02947386 2023-10-05
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
Roswell Park Cancer Institute
Guangdong Association of Clinical Trials
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Biotech Pharmaceutical Co., Ltd.
Yonsei University
YM BioSciences
YM BioSciences